Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-11-07
1999-08-03
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540489, 540492, A01N 4362, C07D27302, C07D24300
Patent
active
059325704
ABSTRACT:
The present invention relates to compounds of formulae I and II: ##STR1## or pharmaceutically acceptable salt forms or prodrugs thereof, which are useful as inhibitors of HIV protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
REFERENCES:
patent: 5521161 (1996-05-01), Malley et al.
patent: 5532357 (1996-07-01), Rodgers et al.
patent: 5610294 (1997-03-01), Lam et al.
Vila et al, Lancet 1997, 350 635-636, "Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide."
Kaltenbach, III Robert Frank
Rodgers James David
DuPont Pharmaceuticals Company
Shah Mukund J.
Truong Tamthom N.
Vance David H.
LandOfFree
1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HI does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HI, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HI will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849646